Miao He

678 total citations
24 papers, 368 citations indexed

About

Miao He is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Miao He has authored 24 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Miao He's work include Ferroptosis and cancer prognosis (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Epigenetics and DNA Methylation (3 papers). Miao He is often cited by papers focused on Ferroptosis and cancer prognosis (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Epigenetics and DNA Methylation (3 papers). Miao He collaborates with scholars based in China, United States and Sweden. Miao He's co-authors include Zhaoying Yang, Yan Jiao, Xiaoyang Wu, Yanqing Li, Yuqi Cai, Ying Yue, Yilin Tai, Yingnan Cui, Éva Morava and Xingyi Zhang and has published in prestigious journals such as PLoS ONE, Chemical Communications and Scientific Reports.

In The Last Decade

Miao He

24 papers receiving 366 citations

Peers

Miao He
Wenhui Zhao China
Shilpy Joshi United States
Yu Xiong China
Wenhui Ma China
Mariam Markouli Greece
Sandra Bien-Möller Germany
Jianchao Zheng China
Wenhui Zhao China
Miao He
Citations per year, relative to Miao He Miao He (= 1×) peers Wenhui Zhao

Countries citing papers authored by Miao He

Since Specialization
Citations

This map shows the geographic impact of Miao He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miao He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miao He more than expected).

Fields of papers citing papers by Miao He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miao He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miao He. The network helps show where Miao He may publish in the future.

Co-authorship network of co-authors of Miao He

This figure shows the co-authorship network connecting the top 25 collaborators of Miao He. A scholar is included among the top collaborators of Miao He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miao He. Miao He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Xiaoli, et al.. (2025). Targeting autophagy to enhance chemotherapy and immunotherapy in oral cancer. Frontiers in Immunology. 15. 1535649–1535649. 5 indexed citations
2.
He, Miao, et al.. (2023). The clinical and genetic features in patients coexisting primary breast and thyroid cancers. Frontiers in Endocrinology. 14. 1136120–1136120. 3 indexed citations
3.
Wang, Ling, Miao He, Zhaoying Yang, et al.. (2022). Cysteine conjugate beta-lyase 2 (CCBL2) expression as a prognostic marker of survival in breast cancer patients. PLoS ONE. 17(6). e0269998–e0269998. 1 indexed citations
4.
Ning, Yan, Ling Wang, Yimin Wang, et al.. (2021). Downregulated mRNA Expression of ZNF385B Is an Independent Predictor of Breast Cancer. International Journal of Genomics. 2021. 1–13. 4 indexed citations
5.
Cai, Yuqi, et al.. (2021). Transcardiac Perfusion of the Mouse for Brain Tissue Dissection and Fixation. BIO-PROTOCOL. 11(5). e3988–e3988. 45 indexed citations
6.
Zhang, Liang, Chaochao Yan, Peng Jiang, et al.. (2020). Age-related gene expression and DNA methylation changes in rhesus macaque. Genomics. 112(6). 5147–5156. 13 indexed citations
7.
Ning, Yan, Keren Wang, Ge Gao, et al.. (2020). <p>Wntless (Wls): A Prognostic Index for Progression and Patient Survival of Breast Cancer</p>. OncoTargets and Therapy. Volume 13. 12649–12659. 4 indexed citations
8.
Park, Julien H., Janine Reunert, Miao He, et al.. (2020). L-Fucose treatment of FUT8-CDG. Molecular Genetics and Metabolism Reports. 25. 100680–100680. 19 indexed citations
9.
He, Miao, et al.. (2020). Rab22a is a novel prognostic marker for cell progression in breast cancer. International Journal of Molecular Medicine. 45(4). 1037–1046. 11 indexed citations
10.
Lin, Hou‐Wen, Yan Jiao, Yanqing Li, et al.. (2020). Low EIF2B5 expression predicts poor prognosis in ovarian cancer. Medicine. 99(5). e18666–e18666. 6 indexed citations
11.
Jiao, Yan, Yanqing Li, Zhuo Fu, et al.. (2019). OGDHL Expression as a Prognostic Biomarker for Liver Cancer Patients. Disease Markers. 2019. 1–9. 25 indexed citations
12.
13.
Zhao, Yue‐Chen, et al.. (2019). Elevated high mobility group A2 expression in liver cancer predicts poor patient survival. Revista Española de Enfermedades Digestivas. 112(1). 27–33. 10 indexed citations
14.
Cui, Yingnan, Yan Jiao, Keren Wang, Miao He, & Zhaoying Yang. (2019). A new prognostic factor of breast cancer: High carboxyl ester lipase expression related to poor survival. Cancer Genetics. 239. 54–61. 19 indexed citations
15.
Zhang, Xueyan, Yingnan Cui, Miao He, Yan Jiao, & Zhaoying Yang. (2019). Lipocalin-1 Expression as a Prognosticator Marker of Survival in Breast Cancer Patients. Breast Care. 15(3). 272–280. 14 indexed citations
16.
Cai, Hongqiao, Yan Jiao, Yanqing Li, et al.. (2019). Low CYP24A1 mRNA expression and its role in prognosis of breast cancer. Scientific Reports. 9(1). 13714–13714. 28 indexed citations
17.
Sun, Liang, et al.. (2019). Low BCL7A expression predicts poor prognosis in ovarian cancer. Journal of Ovarian Research. 12(1). 15 indexed citations
18.
He, Miao, et al.. (2017). Additive effects of cherlerythrine chloride combination with erlotinib in human non-small cell lung cancer cells. PLoS ONE. 12(4). e0175466–e0175466. 17 indexed citations
19.
Zhang, Yifan, Rui Jiang, Jindong Li, et al.. (2013). SMC1A knockdown induces growth suppression of human lung adenocarcinoma cells through G1/S cell cycle phase arrest and apoptosis pathways in vitro. Oncology Letters. 5(3). 749–755. 25 indexed citations
20.
Wolfe, Lynne A., Éva Morava, Miao He, Jerry Vockley, & K. Michael Gibson. (2012). Heritable disorders in the metabolism of the dolichols: A bridge from sterol biosynthesis to molecular glycosylation. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 160C(4). 322–328. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenhui Zhao Breakdown of academic impact, for papers by Shilpy Joshi Breakdown of academic impact, for papers by Yu Xiong Breakdown of academic impact, for papers by Wenhui Ma Breakdown of academic impact, for papers by Mariam Markouli Breakdown of academic impact, for papers by Sandra Bien-Möller Breakdown of academic impact, for papers by Jianchao Zheng
Rankless by CCL
2026